Epilepsy Trial, Recruiting (NCT06701084)

Epilepsy Trial, Recruiting NCT06701084 Sponsor: Boston Children's Hospital Condition: Epilepsy

Printed from Voxsanity (voxsanity.com.au) — NCT06701084 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Epilepsy

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

The infant had their first seizure before 12 months of age
The infant is being enrolled within 6 weeks of the hospital visit related to their seizures
The infant is a patient at Boston Children's Hospital
A parent or caregiver who is the legal guardian of an eligible infant

Who may not be able to join:

Infants whose seizures were simple febrile seizures (seizures caused by a fever in an otherwise healthy child)
Infants whose seizures were directly caused by a short-term illness or medical event, such as infection, bleeding in the brain, abnormal electrolyte levels, stroke, lack of oxygen at birth, or injury
Infants who have already been given a confirmed genetic or acquired cause for their epilepsy, including brain scan results that point to a specific condition such as tuberous sclerosis complex
Infants who have passed away before being enrolled in the trial
Parents or caregivers who are not the legal guardian of the infant

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 27 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Alissa M D'Gama, MD, PhD, Boston Children's Hospital

Phone: 8572185533

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06701084

Sponsor: Boston Children's Hospital

Phase: Not Applicable

Status: Recruiting

Condition: Epilepsy

Trial contact: 8572185533

More information: https://clinicaltrials.gov/study/NCT06701084

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

The infant had their first seizure before 12 months of age
The infant is being enrolled within 6 weeks of the hospital visit related to their seizures
The infant is a patient at Boston Children's Hospital
A parent or caregiver who is the legal guardian of an eligible infant

Who may not be able to join:

Infants whose seizures were simple febrile seizures (seizures caused by a fever in an otherwise healthy child)
Infants whose seizures were directly caused by a short-term illness or medical event, such as infection, bleeding in the brain, abnormal electrolyte levels, stroke, lack of oxygen at birth, or injury
Infants who have already been given a confirmed genetic or acquired cause for their epilepsy, including brain scan results that point to a specific condition such as tuberous sclerosis complex
Infants who have passed away before being enrolled in the trial
Parents or caregivers who are not the legal guardian of the infant

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 27 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Boston Children's Hospital

Registry

ClinicalTrials.gov

Start date

2 September 2021

Est. completion

1 November 2029

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Diagnostic Yield; Short-term clinical utility of genetic testing; Parent-perceived (personal) utility of genetic testing

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov